Related Experiment Videos
Signalling events regulating lymphoid growth and survival
1Infection & Immunity, Tenovus Building, Heath Park, Cardiff CF14 4XX, UK. paul.brennanlab.net
Seminars in Cancer Biology
|October 24, 2001
Summary
Epstein-Barr virus (EBV) manipulates lymphocyte cell cycle and survival pathways. Key viral proteins and induced cytokines promote cell growth and prevent apoptosis, facilitating EBV-driven lymphoproliferation.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Epstein-Barr virus (EBV) infection is associated with significant alterations in lymphocyte behavior.
- Understanding the molecular mechanisms by which EBV promotes lymphocyte proliferation and survival is crucial for comprehending lymphoproliferative disorders.
Purpose of the Study:
- To elucidate the cellular pathways modulated by Epstein-Barr virus (EBV) that contribute to lymphocyte survival and proliferation.
- To identify specific EBV genes and host factors involved in regulating the cell cycle and anti-apoptotic responses during infection.
Main Methods:
- Review and synthesis of existing literature on EBV-host interactions.
- Analysis of the roles of specific EBV proteins (EBNA2A, EBNA-LP, EBNA3C, LMP1, LMP2A) in cellular signaling.
- Examination of the impact of EBV-induced cytokines (IL-6, IL-10) on lymphocyte pathways.
Main Results:
- EBV proteins EBNA2A, EBNA-LP, and EBNA3C regulate early G1 phase cell cycle events.
- EBV infection induces Interleukin-6 (IL-6) and Interleukin-10 (IL-10), which activate signaling pathways promoting proliferation.
- Latent membrane protein 1 (LMP1) activates NF-kappa B to induce anti-apoptotic proteins, while LMP2A also supports lymphocyte survival.
Conclusions:
- EBV employs diverse strategies, including modulation of cell cycle regulators and induction of growth factors, to ensure lymphocyte survival and proliferation.
- The interplay between viral proteins and host signaling machinery is critical for EBV-mediated lymphoproliferation.